| Variables . | Total (n = 42) . | ICU (n = 28) . | Medical department (n = 14) . | P-valuea . |
|---|---|---|---|---|
| Diagnosis of renal proximal tubulopathy (%) | 27 (68)b | 20 (74)b | 7 (54)b | 0.28 |
| Diagnosis of proteinuria >300 mg/g (%) | 34 (85)b | 26 (96)b | 8 (62)b | 0.0095 |
| Diagnosis of renal phosphate leakage (TmPi/GFR <0.77) (%) | 19 (48)b | 14 (52)b | 5 (38)b | 0.51 |
| Serum phosphate, mmol/L | 0.88 (0.76–1.20) | 0.90 (0.74–1.21) | 0.85 (0.77–1.2) | 0.98 |
| Hypophosphataemia, n (%) | 12 (29) | 8 (29) | 4 (29) | 0.58 |
| Normophosphataemia, n (%) | 28 (67) | 18 (64) | 10 (71) | 0.51 |
| Hyperphosphataemia, n (%) | 2 (5) | 2 (7) | 0 (0) | 0.98 |
| RTP | 0.75 (0.59–1.01)c | 0.75 (0.57–0.96)c | 0.81 (0.63–1.07)c | 0.28 |
| TmPi/GFR, mmol/L | 0.76 (0.59–1.04)c | 0.75 (0.57–0.99)c | 0.95 (0.63–1.38)c | 0.11 |
| Intraveinous phosphate supplementation, n (%) | 17 (46)d | 16 (64)d | 1 (8)d | 0.0017 |
| Diagnosis of hyperuricosuria, n (%) | 14 (35)b | 11 (41)b | 3 (23)b | 0.31 |
| Hypouricaemia, n (%) | 18 (44)e | 13 (48)e | 5 (36) | 0.52 |
| SUA, µmol/L | 220 (167–349)e | 213 (153–340)e | 261 (168–392) | 0.48 |
| Fe uric acid value (for hyperuricosuric patients) | 17.6 (13.1–33.3)f | 18.1 (13.4–31.9)f | 15.6 (10.8–42.3)f | 0.67 |
| Diagnosis of normoglycaemic glycosuria, n (%) | 11 (28)g | 9 (35)g | 2 (15)g | 0.27 |
| Glycosuria >0.15 g/L, n (%) | 17 (44)g | 15 (58)g | 2 (15) | 0.017 |
| Glycaemia >1.80 g/L, n (%) | 8 (19) | 8 (29) | 0 (0) | 0.037 |
| Glycosuria value in normoglycaemic patient (<1.80 g/L), g/L | 0.09 (0.04–0.27)g | 0.15 (0.05–0.45)g | 0.23 and 18.80 g/Lg | 0.21 |
| Variables . | Total (n = 42) . | ICU (n = 28) . | Medical department (n = 14) . | P-valuea . |
|---|---|---|---|---|
| Diagnosis of renal proximal tubulopathy (%) | 27 (68)b | 20 (74)b | 7 (54)b | 0.28 |
| Diagnosis of proteinuria >300 mg/g (%) | 34 (85)b | 26 (96)b | 8 (62)b | 0.0095 |
| Diagnosis of renal phosphate leakage (TmPi/GFR <0.77) (%) | 19 (48)b | 14 (52)b | 5 (38)b | 0.51 |
| Serum phosphate, mmol/L | 0.88 (0.76–1.20) | 0.90 (0.74–1.21) | 0.85 (0.77–1.2) | 0.98 |
| Hypophosphataemia, n (%) | 12 (29) | 8 (29) | 4 (29) | 0.58 |
| Normophosphataemia, n (%) | 28 (67) | 18 (64) | 10 (71) | 0.51 |
| Hyperphosphataemia, n (%) | 2 (5) | 2 (7) | 0 (0) | 0.98 |
| RTP | 0.75 (0.59–1.01)c | 0.75 (0.57–0.96)c | 0.81 (0.63–1.07)c | 0.28 |
| TmPi/GFR, mmol/L | 0.76 (0.59–1.04)c | 0.75 (0.57–0.99)c | 0.95 (0.63–1.38)c | 0.11 |
| Intraveinous phosphate supplementation, n (%) | 17 (46)d | 16 (64)d | 1 (8)d | 0.0017 |
| Diagnosis of hyperuricosuria, n (%) | 14 (35)b | 11 (41)b | 3 (23)b | 0.31 |
| Hypouricaemia, n (%) | 18 (44)e | 13 (48)e | 5 (36) | 0.52 |
| SUA, µmol/L | 220 (167–349)e | 213 (153–340)e | 261 (168–392) | 0.48 |
| Fe uric acid value (for hyperuricosuric patients) | 17.6 (13.1–33.3)f | 18.1 (13.4–31.9)f | 15.6 (10.8–42.3)f | 0.67 |
| Diagnosis of normoglycaemic glycosuria, n (%) | 11 (28)g | 9 (35)g | 2 (15)g | 0.27 |
| Glycosuria >0.15 g/L, n (%) | 17 (44)g | 15 (58)g | 2 (15) | 0.017 |
| Glycaemia >1.80 g/L, n (%) | 8 (19) | 8 (29) | 0 (0) | 0.037 |
| Glycosuria value in normoglycaemic patient (<1.80 g/L), g/L | 0.09 (0.04–0.27)g | 0.15 (0.05–0.45)g | 0.23 and 18.80 g/Lg | 0.21 |
Data expressed as median (range) or n (%) when appropriate.
Analysis of ICU versus Medical department.
One missing value in each group.
Two missing values in each group.
Three missing values in the ICU group and two missing values in Medical department.
One missing value in the ICU group.
Regarding 14 patients.
Two missing values in the ICU group and one missing value in medical department.
Bold value: the p is <0.05
| Variables . | Total (n = 42) . | ICU (n = 28) . | Medical department (n = 14) . | P-valuea . |
|---|---|---|---|---|
| Diagnosis of renal proximal tubulopathy (%) | 27 (68)b | 20 (74)b | 7 (54)b | 0.28 |
| Diagnosis of proteinuria >300 mg/g (%) | 34 (85)b | 26 (96)b | 8 (62)b | 0.0095 |
| Diagnosis of renal phosphate leakage (TmPi/GFR <0.77) (%) | 19 (48)b | 14 (52)b | 5 (38)b | 0.51 |
| Serum phosphate, mmol/L | 0.88 (0.76–1.20) | 0.90 (0.74–1.21) | 0.85 (0.77–1.2) | 0.98 |
| Hypophosphataemia, n (%) | 12 (29) | 8 (29) | 4 (29) | 0.58 |
| Normophosphataemia, n (%) | 28 (67) | 18 (64) | 10 (71) | 0.51 |
| Hyperphosphataemia, n (%) | 2 (5) | 2 (7) | 0 (0) | 0.98 |
| RTP | 0.75 (0.59–1.01)c | 0.75 (0.57–0.96)c | 0.81 (0.63–1.07)c | 0.28 |
| TmPi/GFR, mmol/L | 0.76 (0.59–1.04)c | 0.75 (0.57–0.99)c | 0.95 (0.63–1.38)c | 0.11 |
| Intraveinous phosphate supplementation, n (%) | 17 (46)d | 16 (64)d | 1 (8)d | 0.0017 |
| Diagnosis of hyperuricosuria, n (%) | 14 (35)b | 11 (41)b | 3 (23)b | 0.31 |
| Hypouricaemia, n (%) | 18 (44)e | 13 (48)e | 5 (36) | 0.52 |
| SUA, µmol/L | 220 (167–349)e | 213 (153–340)e | 261 (168–392) | 0.48 |
| Fe uric acid value (for hyperuricosuric patients) | 17.6 (13.1–33.3)f | 18.1 (13.4–31.9)f | 15.6 (10.8–42.3)f | 0.67 |
| Diagnosis of normoglycaemic glycosuria, n (%) | 11 (28)g | 9 (35)g | 2 (15)g | 0.27 |
| Glycosuria >0.15 g/L, n (%) | 17 (44)g | 15 (58)g | 2 (15) | 0.017 |
| Glycaemia >1.80 g/L, n (%) | 8 (19) | 8 (29) | 0 (0) | 0.037 |
| Glycosuria value in normoglycaemic patient (<1.80 g/L), g/L | 0.09 (0.04–0.27)g | 0.15 (0.05–0.45)g | 0.23 and 18.80 g/Lg | 0.21 |
| Variables . | Total (n = 42) . | ICU (n = 28) . | Medical department (n = 14) . | P-valuea . |
|---|---|---|---|---|
| Diagnosis of renal proximal tubulopathy (%) | 27 (68)b | 20 (74)b | 7 (54)b | 0.28 |
| Diagnosis of proteinuria >300 mg/g (%) | 34 (85)b | 26 (96)b | 8 (62)b | 0.0095 |
| Diagnosis of renal phosphate leakage (TmPi/GFR <0.77) (%) | 19 (48)b | 14 (52)b | 5 (38)b | 0.51 |
| Serum phosphate, mmol/L | 0.88 (0.76–1.20) | 0.90 (0.74–1.21) | 0.85 (0.77–1.2) | 0.98 |
| Hypophosphataemia, n (%) | 12 (29) | 8 (29) | 4 (29) | 0.58 |
| Normophosphataemia, n (%) | 28 (67) | 18 (64) | 10 (71) | 0.51 |
| Hyperphosphataemia, n (%) | 2 (5) | 2 (7) | 0 (0) | 0.98 |
| RTP | 0.75 (0.59–1.01)c | 0.75 (0.57–0.96)c | 0.81 (0.63–1.07)c | 0.28 |
| TmPi/GFR, mmol/L | 0.76 (0.59–1.04)c | 0.75 (0.57–0.99)c | 0.95 (0.63–1.38)c | 0.11 |
| Intraveinous phosphate supplementation, n (%) | 17 (46)d | 16 (64)d | 1 (8)d | 0.0017 |
| Diagnosis of hyperuricosuria, n (%) | 14 (35)b | 11 (41)b | 3 (23)b | 0.31 |
| Hypouricaemia, n (%) | 18 (44)e | 13 (48)e | 5 (36) | 0.52 |
| SUA, µmol/L | 220 (167–349)e | 213 (153–340)e | 261 (168–392) | 0.48 |
| Fe uric acid value (for hyperuricosuric patients) | 17.6 (13.1–33.3)f | 18.1 (13.4–31.9)f | 15.6 (10.8–42.3)f | 0.67 |
| Diagnosis of normoglycaemic glycosuria, n (%) | 11 (28)g | 9 (35)g | 2 (15)g | 0.27 |
| Glycosuria >0.15 g/L, n (%) | 17 (44)g | 15 (58)g | 2 (15) | 0.017 |
| Glycaemia >1.80 g/L, n (%) | 8 (19) | 8 (29) | 0 (0) | 0.037 |
| Glycosuria value in normoglycaemic patient (<1.80 g/L), g/L | 0.09 (0.04–0.27)g | 0.15 (0.05–0.45)g | 0.23 and 18.80 g/Lg | 0.21 |
Data expressed as median (range) or n (%) when appropriate.
Analysis of ICU versus Medical department.
One missing value in each group.
Two missing values in each group.
Three missing values in the ICU group and two missing values in Medical department.
One missing value in the ICU group.
Regarding 14 patients.
Two missing values in the ICU group and one missing value in medical department.
Bold value: the p is <0.05
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
